Published in Eye (Lond) on June 29, 2012
Genetic determinants of macular pigments in women of the Carotenoids in Age-Related Eye Disease Study. Invest Ophthalmol Vis Sci (2013) 0.99
The heritability of the ring-like distribution of macular pigment assessed in a twin study. Invest Ophthalmol Vis Sci (2014) 0.79
The use of heterochromatic flicker photometry to determine macular pigment optical density in a healthy Australian population. Graefes Arch Clin Exp Ophthalmol (2014) 0.76
Macular xanthophylls, lipoprotein-related genes, and age-related macular degeneration. Am J Clin Nutr (2014) 0.76
Relative Genetic and Environmental Contributions to Variations in Human Retinal Electrical Responses Quantified in a Twin Study. Ophthalmology (2017) 0.75
A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A (2005) 13.44
A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat Genet (2006) 3.96
Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Annu Rev Nutr (2003) 2.63
Lutein, zeaxanthin, and the macular pigment. Arch Biochem Biophys (2001) 2.18
The macular pigment. II. Spatial distribution in primate retinas. Invest Ophthalmol Vis Sci (1984) 2.10
Analysis of the macular pigment by HPLC: retinal distribution and age study. Invest Ophthalmol Vis Sci (1988) 1.96
Dietary modification of human macular pigment density. Invest Ophthalmol Vis Sci (1997) 1.72
Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest Ophthalmol Vis Sci (2001) 1.70
Macular pigment optical density measurement in autofluorescence imaging: comparison of one- and two-wavelength methods. Graefes Arch Clin Exp Ophthalmol (2006) 1.68
The inheritance of scholastric abilities in a sample of twins. I. Ascertainments of the sample and diagnosis of zygosity. Ann Hum Genet (1975) 1.63
Distribution of lutein and zeaxanthin stereoisomers in the human retina. Exp Eye Res (1997) 1.62
Identification and characterization of a Pi isoform of glutathione S-transferase (GSTP1) as a zeaxanthin-binding protein in the macula of the human eye. J Biol Chem (2004) 1.60
Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients. Ophthalmology (2002) 1.48
Age-related maculopathy and the impact of blue light hazard. Acta Ophthalmol Scand (2006) 1.47
Macular pigment in donor eyes with and without AMD: a case-control study. Invest Ophthalmol Vis Sci (2001) 1.45
Individual variations in the spatial profile of human macular pigment. J Opt Soc Am A Opt Image Sci Vis (1997) 1.43
The spectral sensitivity of the human short-wavelength sensitive cones derived from thresholds and color matches. Vision Res (1999) 1.40
Macular pigment and age related macular degeneration. Br J Ophthalmol (1999) 1.39
Relation between dietary intake, serum concentrations, and retinal concentrations of lutein and zeaxanthin in adults in a Midwest population. Am J Clin Nutr (2001) 1.32
Purification and partial characterization of a lutein-binding protein from human retina. Biochemistry (2009) 1.27
Cigarette smoking and retinal carotenoids: implications for age-related macular degeneration. Vision Res (1996) 1.23
Macular pigment density and distribution: comparison of fundus autofluorescence with minimum motion photometry. Vision Res (2003) 1.21
Transport and retinal capture of lutein and zeaxanthin with reference to age-related macular degeneration. Surv Ophthalmol (2008) 1.19
Confidence intervals for the parameters of psychometric functions. Percept Psychophys (1990) 1.13
Macular pigments lutein and zeaxanthin as blue light filters studied in liposomes. Arch Biochem Biophys (2001) 1.13
Spatial profile of macular pigment and its relationship to foveal architecture. Invest Ophthalmol Vis Sci (2008) 1.11
Sex differences in macular pigment optical density: relation to plasma carotenoid concentrations and dietary patterns. Vision Res (1996) 1.08
Macular pigment optical density in a Southwestern sample. Invest Ophthalmol Vis Sci (2000) 1.08
Macular pigment and melanin in age-related maculopathy in a general population. Invest Ophthalmol Vis Sci (2002) 1.07
Further assessment of the complement component 2 and factor B region associated with age-related macular degeneration. Invest Ophthalmol Vis Sci (2008) 1.04
On the age dependency of the macular pigment optical density. Exp Eye Res (2005) 1.03
Macular pigment optical density in a midwestern sample. Ophthalmology (2001) 1.01
Macular pigment shows ringlike structures. Invest Ophthalmol Vis Sci (2006) 1.01
A new instrument for the quantification of macular pigment density: first results in patients with AMD and healthy subjects. Graefes Arch Clin Exp Ophthalmol (2002) 0.99
Macular pigment and percentage of body fat. Invest Ophthalmol Vis Sci (2004) 0.98
Heritability of macular pigment: a twin study. Invest Ophthalmol Vis Sci (2005) 0.96
Resonance Raman imaging of macular pigment distributions in the human retina. J Opt Soc Am A Opt Image Sci Vis (2008) 0.96
Macular pigment density and age-related maculopathy in the Carotenoids in Age-Related Eye Disease Study. An ancillary study of the women's health initiative. Ophthalmology (2007) 0.96
Macular pigment: quantitative analysis on autofluorescence images. Graefes Arch Clin Exp Ophthalmol (2003) 0.95
Macular pigment density and aging, assessed in the normal elderly and those with cataracts and age-related macular degeneration. Am J Ophthalmol (2004) 0.93
The ringlike structure of macular pigment in age-related maculopathy: results from the Muenster Aging and Retina Study (MARS). Invest Ophthalmol Vis Sci (2011) 0.91
Foveal anatomic associations with the secondary peak and the slope of the macular pigment spatial profile. Invest Ophthalmol Vis Sci (2008) 0.89
Heritable features of the optic disc: a novel twin method for determining genetic significance. Invest Ophthalmol Vis Sci (2007) 0.88
Macular pigment density in age-related maculopathy. Graefes Arch Clin Exp Ophthalmol (2004) 0.86
Distribution of macular pigment components, zeaxanthin and lutein, in human retina. Methods Enzymol (1992) 0.85
Effect of cataract in evaluation of macular pigment optical density by autofluorescence spectrometry. Invest Ophthalmol Vis Sci (2011) 0.85
Heritability of macular thickness determined by optical coherence tomography. Invest Ophthalmol Vis Sci (2006) 0.84
Gene-environment interactions and aging visual function: a classical twin study. Ophthalmology (2008) 0.82
Comparison of fundus autofluorescence and minimum-motion measurements of macular pigment distribution profiles derived from identical retinal areas. Perception (2005) 0.81
Macular pigment optical density at four retinal loci during 120 days of lutein supplementation. Ophthalmic Physiol Opt (2007) 0.81
Twin study on cup/disc ratio of the optic nerve head. Br J Ophthalmol (1992) 0.80
Isolation and structural elucidation of the geometrical isomers of lutein and zeaxanthin in extracts from human plasma. J Chromatogr (1992) 0.79
A simple system for the clinical grading of lens opacities. Yan Ke Xue Bao (1988) 0.78
Bootstrap variance estimators for the parameters of small-sample sensory-performance functions. Biol Cybern (1987) 0.78
The sor gene of HIV-1 is required for efficient virus transmission in vitro. Science (1987) 6.16
Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost (2000) 4.81
Mutations in the human retinal degeneration slow (RDS) gene can cause either retinitis pigmentosa or macular dystrophy. Nat Genet (1993) 3.62
A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat Genet (1999) 3.32
Antibiotics carried in general practitioners' emergency bags: four years on. BMJ (1995) 3.22
Failure of chloroquine and proguanil prophylaxis in travellers to Kenya. Lancet (1991) 3.03
Use of a clinical model for safe management of patients with suspected pulmonary embolism. Ann Intern Med (1998) 2.49
The cytotoxic effects of asbestos and other mineral dust in tissue culture cell lines. Br J Exp Pathol (1978) 2.45
Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis. J Clin Oncol (1999) 2.29
The effect of fibre size on the in vitro biological activity of three types of amphibole asbestos. Int J Cancer (1978) 2.24
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. Lancet Oncol (2011) 2.13
A completed screen for mutations of the rhodopsin gene in a panel of patients with autosomal dominant retinitis pigmentosa. Hum Mol Genet (1992) 1.80
Variation of codons 1961 and 2177 of the Stargardt disease gene is not associated with age-related macular degeneration. Arch Ophthalmol (2001) 1.68
Multiple drug reactions in a patient with AIDS. Lancet (1989) 1.55
Oncogenic point mutations in exon 20 of the RB1 gene in families showing incomplete penetrance and mild expression of the retinoblastoma phenotype. Proc Natl Acad Sci U S A (1992) 1.54
Biological effects of tremolite. Br J Cancer (1982) 1.50
Interest in alternative birthplaces among women in Ottawa-Carleton. CMAJ (1990) 1.50
Mapping the transcriptional transactivation function of simian virus 40 large T antigen. J Virol (1991) 1.47
A spotted fever and melaena: acute HIV seroconversion. Int J STD AIDS (1997) 1.44
Autosomal dominant retinitis pigmentosa with apparent incomplete penetrance: a clinical, electrophysiological, psychophysical, and molecular genetic study. Br J Ophthalmol (1993) 1.41
Münchausen's syndrome (HIV infection): a trap for the unwary. Br J Clin Pract (1996) 1.39
The role of aerosol pentamidine prophylaxis. Int J STD AIDS (1993) 1.38
Cholesterol-lowering medications reduce the risk of age-related maculopathy progression. Med J Aust (2001) 1.38
Asbestos and glass fibres in bacterial mutation tests. Mutat Res (1977) 1.35
Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of followup. J Urol (2000) 1.20
In vitro prediction of the pathogenicity of mineral dusts. Br J Exp Pathol (1979) 1.19
Detection of heterozygous mutations in the RB1 gene in retinoblastoma patients using single-strand conformation polymorphism analysis and polymerase chain reaction sequencing. Oncogene (1992) 1.19
Choroidal hypoperfusion in acute posterior multifocal placoid pigment epitheliopathy. An indocyanine green angiography study. Ophthalmology (1995) 1.13
A randomised comparison of 'Casodex' (bicalutamide) 150 mg monotherapy versus castration in the treatment of metastatic and locally advanced prostate cancer. Eur Urol (1998) 1.13
Macular dystrophy associated with mutations at codon 172 in the human retinal degeneration slow gene. Ophthalmology (1994) 1.10
Genotype-phenotype correlation in British families with X linked congenital stationary night blindness. Br J Ophthalmol (2003) 1.08
Treatment of CNS dissemination in systemic lymphoma. J Neurooncol (2007) 1.05
Cycloplegic refraction in preschool children: comparisons between the hand-held autorefractor, table-mounted autorefractor and retinoscopy. Ophthalmic Physiol Opt (2009) 1.03
Corneal light scattering and visual performance in myopic individuals with spectacles, contact lenses, or excimer laser photorefractive keratectomy. Am J Ophthalmol (1993) 1.02
Evidence for genetic heterogeneity within eight glaucoma families, with the GLC1A Gln368STOP mutation being an important phenotypic modifier. Ophthalmology (2001) 1.02
In vitro biological effects of glass fibers. J Environ Pathol Toxicol (1980) 1.02
Phase I trial of sorafenib in patients with recurrent or progressive malignant glioma. Neuro Oncol (2011) 1.01
Optic neuropathy as the presenting feature of HIV infection: recovery of vision with highly active antiretroviral therapy. Br J Ophthalmol (2000) 1.01
Topography and volume measurements of the optic nerve usingen-face optical coherence tomography. Opt Express (2001) 1.00
The in vitro activities of pathogenic mineral dusts. Toxicology (1980) 0.97
National survey of radionuclide gastric emptying studies. Can J Gastroenterol (1997) 0.97
Simian virus 40 host range/helper function mutations cause multiple defects in viral late gene expression. J Virol (1989) 0.97
Pneumococcal sepsis in a splenectomized patient. Br J Gen Pract (1995) 0.97
Macular pigment: quantitative analysis on autofluorescence images. Graefes Arch Clin Exp Ophthalmol (2003) 0.95
In vitro tests for the pathogenicity of mineral dusts. Ann Occup Hyg (1982) 0.95
Cross-talk between signalling pathways and the multidrug resistant protein MDR-1. Br J Cancer (2001) 0.94
Quantitative measurement of quality outcome in malignant glioma patients using an independent living score (ILS). Assessment of a retrospective cohort. J Neurooncol (2003) 0.92
The activity of two types of asbestos in tissue culture. IARC Sci Publ (1980) 0.92
The impact of diabetic retinopathy: understanding the patient's perspective. Br J Ophthalmol (2010) 0.91
Using the OSCE to measure clinical skills performance in nursing. J Adv Nurs (1988) 0.91
Vertebral collapse with quadraparesis due to metastatic gliobla multiforme: case report and review of the literature. J Neurooncol (1993) 0.91
Cyclic macular edema. Am J Ophthalmol (1982) 0.91
A fast, robust pattern recognition asystem for low light level image registration and its application to retinal imaging. Opt Express (1998) 0.90
Association of dietary fish and n-3 fatty acid intake with hemostatic factors in the coronary artery risk development in young adults (CARDIA) study. Arterioscler Thromb Vasc Biol (1998) 0.90
Effects of acute graded exercise on human colonic motility. Am J Physiol (1999) 0.90
Retrospective study of malaria cases treated in Newcastle General Hospital between 1990 and 1996. J Travel Med (1998) 0.89
Expression of Epstein-Barr virus proteins in primary CNS lymphoma in AIDS patients. Neurology (1993) 0.88
The primary treatment trial: changes in the visual field analysis by computer-assisted perimetry. Eye (Lond) (1994) 0.88
Changes in rat serum corticosterone after treatment with metabotropic glutamate receptor agonists or antagonists. J Neuroendocrinol (2001) 0.87
Measuring nursing support during childbirth. MCN Am J Matern Child Nurs (2001) 0.87
An alternative strategy to the use of guinea pigs for the identification of skin sensitization hazard. Food Chem Toxicol (1995) 0.85
The hepatocyte growth factor receptor (MET) gene is not associated with refractive error and ocular biometrics in a Caucasian population. Mol Vis (2009) 0.85
Retinal vascular changes following intravitreal ranibizumab injections for neovascular AMD over a 1-year period. Eye (Lond) (2012) 0.85
Greater emotional distress is associated with accelerated CD4+ cell decline in HIV infection. J Psychosom Res (1997) 0.85
Protective vaccination against virulent Babesia bovis with a low-molecular-weight antigen. Infect Immun (1985) 0.85
Effect of mineral dusts on metabolic cooperation between Chinese hamster V79 cells in vitro. Environ Health Perspect (1983) 0.84
Characteristics of progression of early age-related macular degeneration: the cardiovascular health and age-related maculopathy study. Eye (Lond) (2006) 0.84
The classification of skin irritants by human patch test. Food Chem Toxicol (1997) 0.83
A summary report of the COLIPA international validation study on alternatives to the draize rabbit eye irritation test. Toxicol In Vitro (2010) 0.83
Remember mycobacterial disease in hairy cell leukaemia (HCL). J Infect (2001) 0.83
Leptomeningeal metastases due to melanoma. Int J Oncol (1996) 0.83
Mortality and survival trends in patients with AIDS in north east England from 1984-1992. J Infect (1995) 0.82
Intercellular adhesion molecule (ICAM-1) inhibition can induce tolerance in vivo. Immunol Cell Biol (1991) 0.82
Male pattern baldness. South Med J (2000) 0.82
Ranibizumab treatment for neovascular age-related macular degeneration: from randomized trials to clinical practice. Eye (Lond) (2009) 0.82
The influence of mineral dusts on metabolic co-operation between mammalian cells in tissue culture. Carcinogenesis (1982) 0.82
A single base pair polymorphism in the WT1 gene detected by single-strand conformation polymorphism analysis. Hum Genet (1992) 0.81
T-cell infiltration of primary CNS lymphoma. Neurology (1996) 0.81
Generating mouse models of retinal disease using ENU mutagenesis. Vision Res (2002) 0.81
Validation of skin sensitization assays. Food Chem Toxicol (1995) 0.80
The role of birth weight in myopia--the genes in myopia twin study. Ophthalmic Res (2009) 0.80
Phosphoinositide hydrolysis in vivo with group I metabotropic glutamate receptor agonists. Brain Res (1999) 0.80
A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patients. J Neurooncol (2016) 0.80
Overwhelming pneumoccoccal sepsis in two patients splenectomised more than ten years previously. Scott Med J (1996) 0.80
In vitro effects of man-made mineral fibres. Ann Occup Hyg (1979) 0.80
Testing protocol and recruitment in the genes in myopia twin study. Ophthalmic Epidemiol (2008) 0.80
Diabetic macular oedema: pilot randomised trial of pars plana vitrectomy vs macular argon photocoagulation. Eye (Lond) (2005) 0.80
The effect and mode of action of zinc pyrithione on cell growth. I. In vitro studies. Food Chem Toxicol (1985) 0.79
[Corneal opacity after photorefractive keratectomy with an excimer laser. Cause, objective measurement and functional consequences]. Ophthalmologe (1992) 0.79
Identification of two unknown reading frames in Synechococcus 6301 as homologues of the 10k and 65k antigen genes of Mycobacterium tuberculosis and related heat shock genes in E. coli and Coxiella burnetii. Nucleic Acids Res (1989) 0.79
An expert system rulebase for identifying contact allergens. Toxicol In Vitro (1994) 0.79
Radioaerosol ventilation imaging in ventilator-dependent patients. Technical considerations. Clin Nucl Med (1985) 0.79
Parental smoking and childhood refractive error: the STARS study. Eye (Lond) (2012) 0.79
Analysis of the EFEMP1 gene in individuals and families with early onset drusen. Eye (Lond) (2005) 0.79